Benedetta C. Sallustio

2.0k total citations
85 papers, 1.6k citations indexed

About

Benedetta C. Sallustio is a scholar working on Pharmacology, Transplantation and Pharmacology. According to data from OpenAlex, Benedetta C. Sallustio has authored 85 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmacology, 21 papers in Transplantation and 19 papers in Pharmacology. Recurrent topics in Benedetta C. Sallustio's work include Pharmacogenetics and Drug Metabolism (26 papers), Renal Transplantation Outcomes and Treatments (21 papers) and Drug Transport and Resistance Mechanisms (18 papers). Benedetta C. Sallustio is often cited by papers focused on Pharmacogenetics and Drug Metabolism (26 papers), Renal Transplantation Outcomes and Treatments (21 papers) and Drug Transport and Resistance Mechanisms (18 papers). Benedetta C. Sallustio collaborates with scholars based in Australia, United Kingdom and Netherlands. Benedetta C. Sallustio's co-authors include Raymond G. Morris, Allan M. Evans, Kathleen Knights, Ian S Westley, Andrew A. Somogyi, Roger L. Nation, Janet K. Coller, P J Meffin, Benjamin Noll and Barbara A. Fairchild and has published in prestigious journals such as Circulation, Journal of Pharmacology and Experimental Therapeutics and Frontiers in Immunology.

In The Last Decade

Benedetta C. Sallustio

84 papers receiving 1.6k citations

Peers

Countries citing papers authored by Benedetta C. Sallustio

Since Specialization

Citations

This map shows the geographic impact of Benedetta C. Sallustio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benedetta C. Sallustio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benedetta C. Sallustio more than expected).

Fields of papers citing papers by Benedetta C. Sallustio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benedetta C. Sallustio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benedetta C. Sallustio. The network helps show where Benedetta C. Sallustio may publish in the future.

Co-authorship network of co-authors of Benedetta C. Sallustio

This figure shows the co-authorship network connecting the top 25 collaborators of Benedetta C. Sallustio. A scholar is included among the top collaborators of Benedetta C. Sallustio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benedetta C. Sallustio. Benedetta C. Sallustio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation 2018 ·Pharmacogenetics and Genomics ·Rong Hu, Daniel T. Barratt, Janet K. Coller, Benedetta C. Sallustio, Andrew A. Somogyi	10
2	Validation of a High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for the Determination of Perhexiline and Cis-Hydroxy-Perhexiline Plasma Concentrations 2015 ·Therapeutic Drug Monitoring ·Ian S Westley, (unknown), Benedetta C. Sallustio	2
3	Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial 2013 ·Orphanet Journal of Rare Diseases ·Hiroshi Kitoh, (unknown), Hiroshi Kaneko, Kenichi Mishima, Masaki Matsushita, Izumi Kadono, John D. Horowitz, Benedetta C. Sallustio, Kinji Ohno, Naoki Ishiguro	15
4	Validation of an LC–MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies 2013 ·Journal of Chromatography B ·Zaipul I. Md Dom, Benjamin Noll, Janet K. Coller, Andrew A. Somogyi, Graeme Russ, Dennis A. Hesselink, Teun van Gelder, Benedetta C. Sallustio	19
5	Measurement of Cyclosporine A in Rat Tissues and Human Kidney Transplant Biopsies—A Method Suitable for Small (<1 mg) Samples 2011 ·Therapeutic Drug Monitoring ·Benjamin Noll, Janet K. Coller, Andrew A. Somogyi, Raymond G. Morris, Graeme Russ, Dennis A. Hesselink, Teun van Gelder, Benedetta C. Sallustio	14
6	Effect of CYP2D6 metabolizer status on the disposition of the (+) and (−) enantiomers of perhexiline in patients with myocardial ischaemia 2007 ·Pharmacogenetics and Genomics ·Sally C. Inglis, Megan K. Herbert, (unknown), Janet K. Coller, (unknown), John D. Horowitz, Raymond G. Morris, Robert Milne, Andrew A. Somogyi, Benedetta C. Sallustio	5
7	Enantioselective assay for the determination of perhexiline enantiomers in human plasma by liquid chromatography 2006 ·Journal of Chromatography B ·(unknown), Megan K. Herbert, Julie A. Culbert, Simon M. Pyke, Janet K. Coller, Andrew A. Somogyi, Robert Milne, Benedetta C. Sallustio	14
8	Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma 2005 ·Clinical Biochemistry ·Ian S Westley, Benedetta C. Sallustio, Raymond G. Morris	37
9	The influence of CYP2D6 genotype on trough plasma perhexiline and cis‐OH‐perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia 2005 ·British Journal of Clinical Pharmacology ·(unknown), Janet K. Coller, (unknown), Andrew A. Somogyi, John D. Horowitz, Benedetta C. Sallustio	10
10	Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7 2003 ·Biochemical Pharmacology ·(unknown), John O. Miners, Alan M. F. Stapleton, Anthony J. Thomas, Benedetta C. Sallustio, Kathleen Knights	74
11	Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady‐state dose 2002 ·British Journal of Clinical Pharmacology ·Benedetta C. Sallustio, Ian S Westley, Raymond G. Morris	46
12	In Vitro Covalent Binding of Nafenopin–CoA to Human Liver Proteins 2000 ·Toxicology and Applied Pharmacology ·Benedetta C. Sallustio, (unknown), Chris Drogemuller, Kathleen Knights	33
13	Assessment of Interlaboratory Performance in the Provision of Perhexiline Therapeutic Drug Monitoring Services in Australia 1999 ·Therapeutic Drug Monitoring ·Benedetta C. Sallustio, Raymond G. Morris	8
14	Short-Term Myocardial Uptake of d- and l-Sotalol in Humans: Relation to Hemodynamic and Electrophysiologic Effects 1998 ·Journal of Cardiovascular Pharmacology ·Rebecca H. Ritchie, Benedetta C. Sallustio, John T.Y. Hii, John D. Horowitz	2
15	High-Performance Liquid Chromatography Quantitation of Plasma Lamotrigine Concentrations: Application Measuring Trough Concentrations in Patients With Epilepsy 1997 ·Therapeutic Drug Monitoring ·Benedetta C. Sallustio, Raymond G. Morris	33
16	Effects of gemfibrozil and clofibric acid on the uptake of taurocholate by isolated rat hepatocytes 1997 ·Biochemical Pharmacology ·(unknown), Benedetta C. Sallustio	3
17	High-Performance Liquid Chromatography Determination of Clonazepam in Plasma Using Solid-Phase Extraction 1994 ·Therapeutic Drug Monitoring ·Benedetta C. Sallustio, (unknown), Raymond G. Morris	18
18	Unbound Plasma Phenytoin Concentrations Measured Using Enzyme Immunoassay Technique on the Cobas MIRA Analyser—In Vivo Effect of Valproic Acid 1992 ·Therapeutic Drug Monitoring ·Benedetta C. Sallustio, (unknown)	3
19	Improved High-Performance Liquid Chromatography Assay for Atenolol in Plasma and Urine Using Fluorescence Detection 1991 ·Therapeutic Drug Monitoring ·Raymond G. Morris, (unknown), Benedetta C. Sallustio, R. Zacest	15
20	Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. II. 2-Phenylpropionic acid protein binding. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·Michael E. Jones, Benedetta C. Sallustio, (unknown), P J Meffin	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact